TSE meeting
This article was originally published in The Rose Sheet
Executive Summary
FDA transmissible spongiform encephalopathies advisory committee will hold meeting July 17-18 in Bethesda, Md. to discuss safety of bovine gelatin in cosmetics, food, and oral and topical drugs, Center for Biologics Evaluation & Research announces. Committee also will discuss bovine spongiform encephalopathy in Canada and potential implications for FDA-regulated products...